Gimv, UI Gestion sell Almaviva Santé to Antin

The investment in Almaviva generated a return "well above" Gimv's long-term average return, the firm said. The transaction is expected to close by the end of December.

Almaviva Santé was the first investment of the Gimv Health & Care Fund, which was launched in 2013. It is also the fund's first exit.

Antin Infrastructure Partners used its Antin Infrastructure Partners II fund to invest in Almaviva Santé. The fund was launched in 2013 and held a final close on €2bn in Q2 2014. It aims to invest between €200-400m in European companies.

Almaviva is expected to generate revenues in excess of €300m in 2017, more than triple the €100m posted back in 2012. 

Almaviva plans to pursue further expansion and continue operational improvement of its clinics by extending its care offering.

Company
Founded in 2007 and based in Marseille, Almaviva has grown into the fifth largest private hospital group in France. The company's turnover stood at €258m in 2016.

Almaviva operates 30 clinics, of which 16 are in the Provence-Alpe-Côte d'Azur region and 14 in the Paris region. The group employs more than 3,300 people, as well as 1,100 independent physicians.

People
Gimv – Benoit Chastaing (partner). 
UI Gestion – Olivier Jarrousse (managing partner).
Almaviva Santé – Bruno Marie (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Exits
• France
• Healthcare
• France
• Gimv
• UI Gestion